For treatment of: Bifidumbacterin Forte intestines, immune system.Bifidumbacterin Forte
- For the treatment of internal organs: intestines, immune system
- Appointment: pneumonia, bronchitis, dysbacteriosis, SARS, chronic diseases of the gastrointestinal tract, normalization of intestinal microflora, infectious mononucleosis, gastrointestinal infections, treatment of food toxicoinfections (PTI), food and drug allergies
- Indications for use:
As monotherapy or as part of complex therapy:
— intestinal dysbacteriosis;
— acute intestinal infections of established (shigellosis, salmonellosis, staphylococcal enterocolitis, rotavirus infection) and unknown etiology;
— food toxic infection;
— chronic diseases with gastrointestinal tract damage (peptic ulcer of the stomach and duodenum, pancreatitis, cholecystitis, liver and biliary tract diseases), accompanied by intestinal dysbiosis;
— chronic constipation;
— malabsorption syndrome;
— allergic diseases accompanied by intestinal dysbiosis;
— pneumonia, acute and chronic bronchitis, inflammatory diseases of the urogenital tract, accompanied by intestinal dysbiosis;
— intestinal dysbiosis caused by taking antibiotics, antibacterial drugs, hormones, NSAIDs;
— diarrhea in patients who received long-term treatment with antibiotics and other antibacterial drugs;
— correction of intestinal microbiocenosis and prevention of purulent-inflammatory diseases in surgical patients during preoperative preparation and after operations on the intestines, liver, and pancreas.
For prevention purposes:
— hospital-acquired infections in maternity wards and hospitals;
— dysbacteriosis in children and adults who often suffer from SARS.
— individual intolerance to the medication.
Bifidobacterium bifidum (sorbed on activated carbon) not less than 50 million CFU.
Auxiliary substances: lactose.
- Manufacturer: Partner